Summary |
|
|||||||||||||
Variant origin |
|
|||||||||||||
Variant description |
|
|||||||||||||
Phenotypes |
View phenotypes and curated references for all genotypes (concatenated display).
|
|||||||||||||
Notes |
Mapping and Phenotype information for this QTL, its variants and associated markersJ:54925The authors examined the gentic basis of differences in seizure behaviour using a GABAa receptor agoinst beta CCM (methyl beta-carboline-3 carboxylate). A/J mice are more susceptible to beta-CCM induced myoclonic seizures than C57BL/6J mice in both latency to seizure and proportion of tested mice that seized. A genome wide screen in an F2 population of these parental strains identified a locus on proximal Chromosome 7, near D7Mit308, that displayed an association with seizure susceptibility (chi square =14.8; p = 0.006; n = 267) and seizure latency. This locus was named Bis4 with a LOD score = 3.71 and explaining ~ 22% of the genetic variance and 5-7% of the phenotypic variance for this trait. The best-fitting logistic regression model suggests that the A/J allele and the D7Mit308 locus increases the likelihood of seizures at ~3.3 fold. Candidate genes in this region include Atp1a3, Atp1b3-rs2, Grik5, Scn1b, Gabra5, Gabrb3, Gabrg3 and Szf1. |
|||||||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/05/2024 MGI 6.24 |
|
|